{
  "$schema": "folio-library-entry/v1",
  "id": "10665-90448",
  "blocks": [
    {
      "id": "library/10665-90448/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 8,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "Guiding principles on Ethical \nissues in HIV surveillance\nUNAIDS/WHO Working Group \non Global HIV/AIDS and STI Surveillance\nWHO Library Cataloguing-in-Publication Data\nGuiding principles on Ethical issues in HIV surveillance. UNAIDS/WHO Working Group on \nGlobal HIV/AIDS and STI Surveillance.\nI.World Health Organization.\nISBN 978 92 4 150559 8\t \t\n  \t\n\t\n(NLM classification: WC 503.4)\n© World Health Organization 2013\nAll rights reserved. Publications of the World Health Organization are available on the WHO \nweb site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The front matter of the UNAIDS/WHO Guiding principles on ethical issues in HIV surveillance (2013), with cataloguing data, ISBN and copyright notice. It includes acknowledgements and a table of contents. The contents run from ethical guidance and the history of research ethics through data collection and obligations to disseminate data and intervene, to conclusions and references.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Acronyms and abbreviations",
      "pageStart": 8,
      "pageEnd": 9,
      "target": "../sections/sec-000-acronyms-and-abbreviations.md",
      "narrative": null,
      "content": "ANC\t\n\t\nantenatal clinic\nCDC\t\n\t\nCentres for Disease Control and Prevention\nCIOMS\t \t\nCouncil for International Organizations of Medical Sciences\nDHHS\t\n\t\n(US) Department of Health and Human Services\nGPA\t\n\t\n(WHO’s) Global Programme on AIDS\nIDU\t\n\t\ninjecting drug user\nMSM\t\n\t\nmen who have sex with men\nNBAC\t\n\t\nNational Bioethics Advisory Commission\nNGO\t\n\t\nnongovernmental organization\nOPRR\t\n\t\nOffice for Protection of Research Risks (USA)\nPEPFAR\t\t\nUS President’s Emergency Plan for AIDS Relief\nPMTCT\t \t\nprevention of mother-to-child transmission (of HIV)\nSTI\t\n\t\nsexually transmitted infection\nUAT\t\n\t\nunlink",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A list of acronyms and abbreviations used in the HIV surveillance ethics guidelines.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Summary of the guiding principles",
      "pageStart": 9,
      "pageEnd": 9,
      "target": "../sections/sec-001-summary-of-the-guiding-principles.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Notification: name-based surveillance",
      "pageStart": 9,
      "pageEnd": 9,
      "target": "../sections/sec-002-a-notification-name-based-surveillance.md",
      "narrative": null,
      "content": "Notification: name-based surveillance\nGuidance 1. Name-based HIV case reporting (as contrasted with anonymous or coded reporting) can be \njustified only if data can be maintained in a confidential manner. The data should be used only for purposes \nrelated to public health (and not for discrimination or criminalization). Public health registries must be \ngoverned by the strictest rules of data protection and confidentiality.\nGuidance 2. Data should be shared with other public health agencies only if adequate security measures \nare in place and the reason is justified by a legitimate public heal",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives guidance that name-based HIV case reporting is justified only with strict confidentiality and use solely for public health, and that data be shared only with adequate security and the stricter privacy standard.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Informed consent",
      "pageStart": 9,
      "pageEnd": 10,
      "target": "../sections/sec-003-b-informed-consent.md",
      "narrative": null,
      "content": "Informed consent\nGuidance 3. All surveillance classified as research should be reviewed by ethical review boards (or human \nsubjects’ research oversight committees) to ensure that the consent process fully informs potential \nparticipants about:\n\n\nthe public health goals of the study, \n\n\ntheir freedom to decline to participate, \n\n\nthe need to ask sensitive questions about sex and other behaviours linked to HIV transmission, \n\n\nthe nature of the risks and benefits of participation, \n\n\nthe availability of services to assist the individual with any negative consequence of participation,",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out guidance on informed consent for HIV surveillance, requiring ethics review of research surveillance and listing what participants must be told, including risks, benefits and freedom to decline. It also addresses community consultation and opt-out approaches, citing the Kenya AIDS Indicator Survey.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Vulnerable populations",
      "pageStart": 10,
      "pageEnd": 11,
      "target": "../sections/sec-004-c-vulnerable-populations.md",
      "narrative": null,
      "content": "Vulnerable populations\nGuidance 7. Understanding the patterns of sexual and drug-using behaviour among adolescents justifies \nstudies involving adolescents. However, they must understand the risks and benefits of participating in \nsurveillance activities. Explaining the risks and benefits is often possible among those aged 15–18 years.3 \nChildren below the age of 15 years, who lack the capacity to understand the risks and benefits of participation, \ncan only participate with parental consent. Such studies should provide, through referral, \n\n\npsychological and social support services, if need",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives guidance on involving vulnerable populations in HIV surveillance, including adolescents, who may consent from around 15 while younger children need parental consent and support services. It also covers groups such as sex workers, people who use drugs and men who have sex with men, stressing protection from legal harm and limits of confidentiality.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Unlinked anonymous testing (UAT)",
      "pageStart": 11,
      "pageEnd": 11,
      "target": "../sections/sec-005-d-unlinked-anonymous-testing-uat.md",
      "narrative": null,
      "content": "Unlinked anonymous testing (UAT)\nGuidance 13. Unlinked anonymous testing (UAT) occurs when persons are tested for HIV but the test and \nresults are not linked to any identifying information. The participants are not provided with their results. \nUAT is often done without informed consent. It should be used for surveillance only when data from clinical \nsettings and other studies cannot provide the information necessary for surveillance. All study proposals \nusing UAT should be reviewed by committees capable of evaluating both the epidemiological and ethical \nissues involved. Those who conduct",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives guidance on unlinked anonymous HIV testing, which should be used only when other data cannot meet surveillance needs, be reviewed for ethical and epidemiological soundness and offer participants a way to learn their status.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Data use",
      "pageStart": 11,
      "pageEnd": 12,
      "target": "../sections/sec-006-e-data-use.md",
      "narrative": null,
      "content": "Data use\nGuidance 17. Surveillance efforts can be justified only if they will help prevent the spread of HIV or will be \nused for directing resources to those already infected. When there is resistance to effective interventions or \nresources are scarce, surveillance may be used as a basis for advocacy and empowering the most vulnerable \npopulations. \nGuidance 18. The results of surveillance must always be communicated to stakeholders and the community. \nAny censoring of surveillance data must be challenged. Community advisory boards, ethics review \ncommittees and other oversight bodies charge",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives guidance that HIV surveillance is justified only if it helps prevention or directs resources, that results must be shared with communities, and that people at risk should be referred to services or the project should advocate for them.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introduction",
      "pageStart": 12,
      "pageEnd": 14,
      "target": "../sections/sec-007-1-introduction.md",
      "narrative": null,
      "content": "Why do we need ethical guidelines for second generation surveillance?\nIn 2000, the World Health Organization (WHO) and Joint United Nations Programme on HIV/AIDS (UNAIDS) \npublished the Guidelines for second generation HIV surveillance.(1) The guidelines are a series of modules \nreleased over the past decade, designed to address the complexity of different HIV epidemic contexts \nand meet the planning needs of national programmes. The earlier surveillance systems were focused on \nstrategies for determining the prevalence of both asymptomatic and symptomatic HIV infection. While \nthey helped to",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces the need for ethical guidelines for second generation HIV surveillance, which since 2000 has added behavioural data and focused on populations at higher risk. It argues that accurate surveillance is essential to control the epidemic and that there may be a duty to conduct it. It identifies the intended users, including ministries, NGOs, community advisory boards and ethics committees.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Overview of national and international ethical guidelines on surveillance",
      "pageStart": 14,
      "pageEnd": 15,
      "target": "../sections/sec-008-b-overview-of-national-and-international-ethical.md",
      "narrative": null,
      "content": "Overview of national and international ethical guidelines on surveillance \nThe modern era of medical ethics began with the promulgation of the Nuremberg Code in 1947. Nuremberg \nmarked the first of three major phases in the evolution of medical ethics. The first twenty years or so \nafter Nuremberg marked the articulation of ethical principles governing research, with less effort given to \ndeveloping the means to enforce those principles. During the second phase of evolution, in the wake of \nscandals such as the Tuskegee syphilis study in the United States, a new emphasis was placed on creating",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reviews national and international ethical guidelines relevant to surveillance, tracing medical ethics from the Nuremberg Code through phases of articulation and oversight following scandals like the Tuskegee study. It notes how guidelines treat epidemiological studies and the use of existing records and biological specimens.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Medical ethics and the ethics of epidemiological research: a literature review",
      "pageStart": 15,
      "pageEnd": 17,
      "target": "../sections/sec-009-c-medical-ethics-and-the-ethics-of-epidemiologic.md",
      "narrative": null,
      "content": "Medical ethics and the ethics of epidemiological research: a literature review \nThe ethical principles for the protection of human subjects articulated in Nuremberg and Helsinki, as we have \nnoted, were based on a common set of principles, stressing the absolute need to prioritize the rights of the \nindividual over that of society.(16) Thus, there could be no exceptions to voluntary participation and informed \nconsent.(16) Nuremberg and Helsinki and the first efforts to adopt national guidelines on research ethics \nwere, after all, rooted in a distinct historical period of revelations of great",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reviews literature on medical and epidemiological research ethics, noting that Nuremberg and Helsinki prioritized the individual over society with no exceptions to consent. It describes how later guidance, including CIOMS, adapted these principles to population research and stressed building ethical review capacity in host countries.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Research, practice and surveillance",
      "pageStart": 17,
      "pageEnd": 18,
      "target": "../sections/sec-010-d-research-practice-and-surveillance.md",
      "narrative": null,
      "content": "Research, practice and surveillance\nWith so much attention devoted to the standards that ought to govern medical research and to the \nmechanisms that could best ensure ethical oversight, it was deemed crucial to distinguish that domain of \nclinical practice which was not subject to the same regulatory norms. \nThe Declaration of Helsinki (1964) drew “a fundamental distinction…between medical research for which \nthe aim is essentially diagnostic or therapeutic for a patient, and medical research, the essential object \nof which is purely scientific and without implying direct diagnostic or therap",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Discusses the distinction between research and practice, from the Declaration of Helsinki onward, and the difficulty of classifying surveillance. It concludes that the ethical guidelines should apply to second generation surveillance either way, with mechanisms needed if it is treated as practice.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Public health and mandatory notification",
      "pageStart": 18,
      "pageEnd": 20,
      "target": "../sections/sec-011-e-public-health-and-mandatory-notification.md",
      "narrative": null,
      "content": "Public health and mandatory notification\nIn many nations, there is a long history of governmentally mandated and conducted public health surveillance \nthat has been the primary source of data relevant to the understanding of patterns of morbidity and mortality, \nor the evaluation of efforts designed to limit the impact of disease outbreaks and epidemics.  Where such \nsurveillance exists as a matter of law or official regulation, it typically imposes on specified individuals \n(generally health-care workers) or institutions the duty to report information about identifiable persons \nto public hea",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Examines mandatory public health notification, under which health workers must report identifiable cases to authorities by law, often without consent. It discusses how ethics bodies have accepted such breaches of consent for public health while recognizing deep disagreement in the case of HIV.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Data collection for HIV surveillance",
      "pageStart": 20,
      "pageEnd": 22,
      "target": "../sections/sec-012-2-data-collection-for-hiv-surveillance.md",
      "narrative": null,
      "content": "Public health surveillance: the role of mandatory notification\nSurveillance was the foundation on which the new public health was built, not only in the United States \nbut also in Europe. The move toward the reporting of disease by name to health officials in the United \nStates was paralleled in Europe, driven in part by the cholera epidemics of the nineteenth century. As \ndisease notification began to emerge as a tool for epidemic control, it was bolstered by the more well-\nestablished reporting of vital statistics, the registration of births, marriages and deaths. While vital statistics \nwer",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Traces the history of name-based disease notification in the United States and Europe, rooted in nineteenth-century epidemic control and vital registration. It describes the shift from AIDS to HIV case reporting and the debate over names versus coded identifiers, including in resource-limited settings. It ends by discussing privacy when linking HIV data with other databases and restating guidance on name-based reporting and data sharing.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Integrated biological and behavioural surveillance",
      "pageStart": 22,
      "pageEnd": 22,
      "target": "../sections/sec-013-b-integrated-biological-and-behavioural-surveill.md",
      "narrative": null,
      "content": "Integrated biological and behavioural surveillance",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A section heading for integrated biological and behavioural surveillance, with no further text.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Individuals, local context and the consent process",
      "pageStart": 22,
      "pageEnd": 24,
      "target": "../sections/sec-014-individuals-local-context-and-the-consent-proces.md",
      "narrative": null,
      "content": "A central feature of second generation surveillance is the incorporation of behavioural studies designed \nto provide a better understanding of dynamics of the epidemic in low-level, concentrated and generalized \nstates.(66) In each instance, the goal is to understand who is at risk for infection; what social, cultural and \nstructural factors explain the vulnerability and the prospect of further transmission; what interventions have \nbeen effective or ineffective in stemming the spread of HIV.\nEvaluating a National Surveillance System\nBehavioural surveillance studies typically focus on groups a",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Discusses consent in behavioural studies within second generation HIV surveillance, which gather highly sensitive data on sexual practices and drug use from groups such as sex workers, men who have sex with men and people who inject drugs. It argues that subject selection must be epidemiologically justified so vulnerable groups are not unduly burdened. Participants must give fully informed, affirmative opt-in consent that takes account of local language, beliefs and history. Opt-out procedures are judged unacceptable for face-to-face studies.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Role of community consultation in the consent process",
      "pageStart": 24,
      "pageEnd": 25,
      "target": "../sections/sec-015-role-of-community-consultation-in-the-consent-pr.md",
      "narrative": null,
      "content": "As noted, researchers are obliged to protect the rights of individual subjects through an informed consent \nprocess. Both for surveillance involving contact with individuals as well as the investigation of already \nexisting records, as discussed above, an additional step will prove vital: consultation with those who may \nrepresent the community at large. In its report The ethics of research related to health care in developing \ncountries, the Nuffield Council on Bioethics noted that in some nations such community consultation is \nrequired as a matter of law. In addressing this issue, the US NB",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Argues that, alongside individual consent, consultation with community representatives is vital for HIV surveillance, citing the Nuffield Council and the US National Bioethics Advisory Commission. It notes that community permission cannot replace individual consent and gives the Kenya AIDS Indicator Survey as an example where late consultation lowered participation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Unique issues of consent with minors and the role of parents in the consent process",
      "pageStart": 25,
      "pageEnd": 25,
      "target": "../sections/sec-016-unique-issues-of-consent-with-minors-and-the-rol.md",
      "narrative": null,
      "content": "The very basic principles of research ethics, which seek to protect the right of individuals to not participate \nin investigations if that is their choice, also require the protection of vulnerable individuals who may not \nhave the psychological or legal capacity to choose. The definition of when an individual reaches the legal \nage of majority may differ among nations, but where that threshold has not been passed, parents are \nroutinely required to give consent for the participation of their children. Such consent does not automatically \nguarantee that children will participate. Depending on",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Examines consent for minors in HIV surveillance, where parental consent and child assent may conflict with the need to interview adolescents about sexual behaviour, citing CIOMS guidance. It sets out conditions under which adolescents might participate without parental permission and stresses access to counselling and support services.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Impact of social context on the capacity for consent: prisons and clinical settings",
      "pageStart": 25,
      "pageEnd": 26,
      "target": "../sections/sec-017-impact-of-social-context-on-the-capacity-for-con.md",
      "narrative": null,
      "content": "Settings in which individuals receive medical care, such as prenatal clinics, STI clinics, TB treatment centres \nand hospitals, provide a natural context for second generation surveillance. Inevitably, patients who are \nrecruited to studies may believe that they have no alternative but to agree to participate. They may feel that \ntheir treatment will be compromised or interrupted if they choose to not participate in second generation \nsurveillance studies or if they choose to withdraw from studies after agreeing to join. As one research team \nnoted, “in developing countries, where many partici",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that patients in clinics and prisoners may feel unable to refuse surveillance studies, fearing their care or treatment will suffer. It recommends community consultation, having staff not involved in care obtain consent, and special scrutiny by ethics committees of prisoners' voluntary choice.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Unique issues of consent with vulnerable populations",
      "pageStart": 26,
      "pageEnd": 27,
      "target": "../sections/sec-018-unique-issues-of-consent-with-vulnerable-populat.md",
      "narrative": null,
      "content": "The problem of the coercive impact of undue inducements extends beyond prison populations. In poor \nor marginalized populations, small offers or payments to potential participants in second generation \nsurveillance may be hard to refuse. In relatively wealthy countries, this is an issue that affects the \nimpoverished and marginalized minorities. In nations where poverty is widespread, offers by external \ninvestigators with access to resources may produce, however inadvertently, pressures to participate in \nsurveillance, which undermine the principle of voluntary consent. The 2002 CIOMS Interna",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Discusses how payments or services may unduly induce poor or marginalised people to join surveillance, citing CIOMS guidelines and noting the limits of local ethics review. It stresses informed, voluntary consent, enforceable confidentiality and clearly stated limits to confidentiality for the most-at-risk populations.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-019",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Unique issues of consent with women",
      "pageStart": 27,
      "pageEnd": 28,
      "target": "../sections/sec-019-unique-issues-of-consent-with-women.md",
      "narrative": null,
      "content": "The 2002 CIOMS International ethical guidelines for biomedical research involving human subjects \nmaintained that husbands or heads of households may not consent on behalf of women. Nonetheless, in \nmany societies, the father, husband or family head is expected to make all decisions regarding sensitive \nfamily issues. Women and other family members who fail to submit to male authority may be subject to \ndomestic violence, divorce or social ostracism. The refusal to involve women in studies because of such \ncultural constraints could thwart investigations crucial to women’s interests. In the Un",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Considers consent for women in societies where men are expected to decide, noting CIOMS's position that husbands may not consent on women's behalf and the NBAC's narrow exception allowing supplemental male permission. It concludes that a woman's own consent is required and that lack of male approval must never exclude her.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-020",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Confidentiality",
      "pageStart": 28,
      "pageEnd": 29,
      "target": "../sections/sec-020-confidentiality.md",
      "narrative": null,
      "content": "As noted, CIOMS, in its 2002 revision of International ethical guidelines for biomedical research involving \nhuman subjects, established an obligation on the part of investigators to safeguard the confidentiality of \nsubjects’ research data. The Nuffield Council on Bioethics also emphasized protecting the security and \nconfidentiality of data.(83) So too do the 2009 CIOMS Guidelines on epidemiological research.\nThe protection of confidentiality in the context of research and other surveillance-related investigations \nhas two sources. On a pragmatic level, the failure to provide such assurances",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the ethical and practical reasons for protecting confidentiality in HIV surveillance, citing CIOMS and the Nuffield Council and a study in Côte d'Ivoire where fear of disclosure lowered testing. It addresses data security and legal reporting requirements, stating that participants must be told of any limits to confidentiality.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-021",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Anonymous unlinked surveillance",
      "pageStart": 29,
      "pageEnd": 32,
      "target": "../sections/sec-021-c-anonymous-unlinked-surveillance.md",
      "narrative": null,
      "content": "Anonymous unlinked surveillance\nWith the identification of HIV in 1984, it became clear that an understanding of the dimensions of the AIDS \nepidemic would require more than a careful detailing of the incidence and prevalence of overt symptoms \nof the disease. To enable public health authorities in nations with well-developed public health and health-\ncare systems to target and evaluate preventive interventions and plan for the health-care services that \nwould be required in the future as those with infection progressed to symptomatic conditions, knowledge \nof the prevalence of HIV infection w",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Traces the history and ethics of unlinked anonymous HIV testing of blood collected for other purposes, which became the backbone of surveillance in generalised epidemics. It describes how US authorities and a 1985 Hastings Center group judged it ethical, and how WHO's 1989 guidance supported it. The section then covers growing debate as treatment became available and the case for informing people of their status grew. It concludes that women in antenatal clinic surveillance must also be referred to prevention of mother-to-child transmission services.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-022",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Individual consent to blood drawn specifically for HIV surveillance",
      "pageStart": 32,
      "pageEnd": 33,
      "target": "../sections/sec-022-individual-consent-to-blood-drawn-specifically-f.md",
      "narrative": null,
      "content": "While much of the discussion on UAT had focused on ANCs and the needs and claims of women, there \nwas also increasing uncertainty about the ethics of UAT in population-based household surveys. Despite \nthe importance of studies drawn from ANCs, there was growing concern that they might not, in fact, \nprovide the most accurate characterization of the prevalence of HIV infection in the population at large. \nThey certainly did not permit the linkage of behavioural data with serostatus. Household surveys drawn \nfrom sample populations, although very expensive and complex, were thus deemed necessar",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Discusses consent for blood drawn specifically for HIV testing in household surveys, where direct contact with participants raises the question of how they should learn their results. It concludes that participants must be offered the chance to learn their results through survey teams, mobile units or local clinics.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-023",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Use of collected data",
      "pageStart": 33,
      "pageEnd": 33,
      "target": "../sections/sec-023-3-use-of-collected-data.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-024",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Obligation to use data",
      "pageStart": 33,
      "pageEnd": 33,
      "target": "../sections/sec-024-a-obligation-to-use-data.md",
      "narrative": null,
      "content": "Obligation to use data\nThere is now international consensus that research in a given population is justified only if the results of \nstudies will provide benefit to the populations from which participants are drawn. Surveillance activities \nhave always been justified in terms of the population-level benefits that would follow. In the 2000 revision \nof the Declaration of Helsinki, the WMA declared, “Medical research is only justified if there is a reasonable \nlikelihood that the populations in which the research is carried out stand to benefit from the results of the \nresearch.”(102) The 2002 C",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Argues that surveillance, like research, is justified only if it benefits the populations studied, citing the Declaration of Helsinki and CIOMS, and that ethics committees should consider how data will be used. It notes that surveillance can support advocacy for vulnerable groups.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-025",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Obligation to disseminate data",
      "pageStart": 33,
      "pageEnd": 34,
      "target": "../sections/sec-025-b-obligation-to-disseminate-data.md",
      "narrative": null,
      "content": "Obligation to disseminate data\nDissemination of findings represents a benefit to which the participants in surveillance-related activities \nhave an ethical claim. In stressing the imperative for researchers from developed countries to make good-\nfaith efforts to ensure that participants in a clinical trial have access to the products shown to be effective in \ncompleted research, the US NBAC stressed the importance of communicating results to the communities \nin which investigations take place. As one group of international researchers note, “At a minimum, if \nresearchers collect data in a coun",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the ethical obligation to share surveillance findings with participants and communities, citing NBAC, international researchers and the Nuffield Council. It adds guidance that, when results could harm the population, risks should be minimised in consultation with community representatives.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-026",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Obligation to intervene at the community level",
      "pageStart": 34,
      "pageEnd": 34,
      "target": "../sections/sec-026-c-obligation-to-intervene-at-the-community-level.md",
      "narrative": null,
      "content": "Obligation to intervene at the community level\nResearchers and others who conduct surveillance may not be able to ensure that vulnerable communities \nhave access to the services that surveillance reveals would be helpful in preventing the spread of HIV, \nsuch as condoms, supportive services for women or needle exchange programmes. One function of pre-\nsurveillance consultation with community advisory boards and ethics review committees would be to \ndelineate the shared understanding of what obligations, if any, those who conduct surveillance will have in \nthis regard at the conclusion of the s",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Notes that surveillance teams may not be able to ensure services such as condoms or needle exchange, and gives guidance that investigators should agree in advance with community boards and ethics committees what advocacy role they will play.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-027",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Obligation to intervene at the individual level",
      "pageStart": 34,
      "pageEnd": 36,
      "target": "../sections/sec-027-d-obligation-to-intervene-at-the-individual-leve.md",
      "narrative": null,
      "content": "Obligation to intervene at the individual level\nThose conducting integrated behavioural and biological studies and surveillance activities may, during the \ncourse of the interview, become aware that a participant is placing himself or herself at risk because of a \nlack of information about how HIV is acquired and transmitted, limited access to preventive services or \npsychosocial stressors. Individuals may also reveal that they themselves are being placed at risk because \nof the coercive or threatening behaviour of their sexual partners. While it may be beyond the immediate \nrole of the invest",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Discusses obligations when interviews reveal that participants are at risk from lack of information, lack of services or coercive partners, recommending referral to appropriate services. Where referrals are impossible, it says the project itself should advocate for services with ethical oversight bodies.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-028",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Summary and Conclusions: ethical implications of type of epidemic",
      "pageStart": 36,
      "pageEnd": 38,
      "target": "../sections/sec-028-4-summary-and-conclusions-ethical-implications-o.md",
      "narrative": null,
      "content": "implications of type of epidemic\nThroughout this discussion, the consultations  and in the guidelines that have emerged from it, a number \nof themes have been salient. Despite the emphasis on the importance of protecting the rights of individuals \nin the context of surveillance and the limits such concerns may have for surveillance as an activity, it is \nworth re-emphasizing that there is an ethical obligation to undertake surveillance precisely because of the \npotential for prevention of disease, suffering and death. It is here that the linkage between surveillance \nas a data-gathering activi",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Concludes that there is an ethical obligation to conduct HIV surveillance because of its potential to prevent disease and death, but notes the challenge of providing ethical oversight for surveillance outside research. It stresses confidentiality and consent given stigma and discrimination linked to HIV. It then explains how ethical concerns differ between low-level, concentrated and generalised epidemics.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-029",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Annex: List of guidelines from the WHO/UNAIDS Working Group",
      "pageStart": 38,
      "pageEnd": 39,
      "target": "../sections/sec-029-annex-list-of-guidelines-from-the-whounaids-work.md",
      "narrative": null,
      "content": "UNAIDS Working Group\nTitle\nYear\nTopic \nHIV surveillance among hard to reach populations\n2011\nUpdate on methodologies for conducting HIV \nsurveillance among  most-at-risk populations. \nGuidelines on Estimating the Size of Populations Most \nat Risk to HIV\n (UNAIDS/WHO)\n2010\nUpdate on methodologies for estimating the size of \nmost-at-risk populations.\nhttp://www.globalhealthsciences.ucsf.edu/PPHG/\nsurveillance/who_trainings.html\nTesting Technologies in Surveillance:\nSelection, Evaluation, and Implementation: update \n2009\n2009\nAn update in guidance on selecting and utilizing  \nappropriate HIV test",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "An annex listing guidelines produced by the WHO/UNAIDS working group on HIV surveillance from 2000 to 2011, with their topics and web links, such as guides on population size estimation, testing technologies and triangulation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/prose-sec-030",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "References",
      "pageStart": 39,
      "pageEnd": 48,
      "target": "../sections/sec-030-references.md",
      "narrative": null,
      "content": "1.\t\nUNAIDS/WHO. Guidelines for second generation HIV surveillance. Geneva, UNAIDS/WHO, 2000.\n2.\t\nWorld Health Organization. Report of the technical discussions at the twenty-first World Health \nAssembly on “National and global surveillance of communicable diseases”. Geneva, WHO, May 1968 \n(A21/Technical Discussions/5).\n3.\t\nCenters for Disease Control and Prevention. Comprehensive plan for epidemiologic surveillance. \nAtlanta, Georgia, CDC, August 1986.\n4.\t\nThe National Commission for the Protection of Human Subjects of Biomedical and Behavioral \nResearch. The Belmont report: ethical principles",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The reference list for the guidelines, citing mainly bioethics codes, CIOMS and Nuffield guidance and HIV surveillance literature, ending with WHO HIV/AIDS Department contact details and the ISBN.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-90448/blocks/figure-img-p048-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 48,
      "pageEnd": 48,
      "target": "../images/img-p048-1.webp",
      "narrative": "draft",
      "content": "An ISBN barcode for 9789241505598.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    }
  ]
}
